Top

Reactions Weekly

Published in:

01-11-2022 | Everolimus | Case report

Everolimus/octreotide

Lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2022

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Country of occurrence, reporter country and primary source country not stated. Abstract presented at CHEST 2022 NASHVILLE, Oct. 2022.

WU SS, et al. TYPE 1 MULTIPLE ENDOCRINE NEOPLASIA-ASSOCIATED TRACHEOBRONCHIAL TUMORS MANAGED BY RIGID BRONCHOSCOPY-DIRECTED MULTIMODAL TUMOR DESTRUCTION. Chest 162 (Suppl.): A1640-A1641, No. 4, Oct 2022. Available from: URL: http://doi.org/10.1016/j.chest.2022.08.1374 [abstract]

Title: Everolimus/octreotide
Lack of efficacy: case report
Publication date: 01-11-2022
Publisher: Springer International Publishing
Keywords: Everolimus
Neuroendocrine Tumor
Published in: Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-022-27061-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Everolimus/octreotide

Lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2022

Multiple drugs

Multiple drugs

Ulipristal

Amygdalin overdose and misuse

Levodopa/carbidopa

Levothyroxine sodium